[Form 4] Lifevantage Corporation Insider Trading Activity

Rhea-AI Filing Summary

Alissa Neufeld, General Counsel of Lifevantage Corp (LFVN), received equity awards on 08/26/2025. The Form 4 shows an award of 9,036 stock units and 13,554 Performance Restricted Stock Units (PRSUs). After the grant, Ms. Neufeld beneficially owns 100,605 shares of common stock and 13,554 PRSU equivalents. The stock units vest with 5/12 of the award on September 10, 2026 and the remainder in equal installments on the tenth day of the third month of each of seven subsequent calendar quarters. The PRSUs vest only if performance targets are met (target payout shown); upon maximum performance the award may pay up to 200% of target, with vested portions scheduled 34% on Sept 10, 2026, 33% on Sept 10, 2027, and 33% on Sept 10, 2028.

Positive

• Alignment with shareholders: PRSUs link pay to performance and can pay up to 200% of target if metrics are exceeded
• Retention-focused vesting: Time-based vesting schedule (starting 9/10/2026 and continuing quarterly) encourages continued service
• No cash outlay: Awards issued at $0 purchase price, conserving company cash

Negative

• Potential dilution: New shares underlying PRSUs and stock units will increase share count if and when vested and settled
• Contingent value: PRSU amounts depend on meeting unspecified performance criteria; value is uncertain until metrics are reported

Insights

Corporate Governance Expert

TL;DR: Typical officer equity grant structured for retention and performance alignment; contingent vesting ties pay to service and company metrics.

The grant combines time-based stock units and performance-based RSUs, which is a common governance practice to align executive incentives with long-term shareholder value. Time-based vesting begins 9/10/2026 and continues quarterly, promoting retention. The PRSU component is contingent on achieving specified financial criteria and can pay up to 200% at maximum performance, which strengthens pay-for-performance linkage. There is no cash consideration paid (price $0), and the filing reflects routine compensation rather than a change in control or special one-time cash award. This disclosure appears complete for a Form 4 reporting an equity grant.

Securities/Compensation Analyst

TL;DR: Grant size is modest relative to total outstanding shares disclosed here and looks targeted at retention, not immediate dilution of existing holders.

The reporting person acquired 9,036 stock units and 13,554 PRSUs resulting in beneficial ownership totals reported as 100,605 common shares and 13,554 PRSU equivalents. The PRSU payout is performance-contingent and vests over three years if targets are achieved, which helps manage near-term dilution risk while offering upside at superior performance (200% of target at maximum). The filing indicates standard Section 16 reporting and contains the specific vesting schedule required for investor assessment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Neufeld Alissa

(Last) (First) (Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI UT 84043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	08/26/2025		A		9,036	A	$0	100,605	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Restricted Stock Units(2)	(3)	08/26/2025		A	V	13,554		(3)	(3)	Common Stock	13,554	$0	13,554	D

Explanation of Responses:

1. This reflects a stock unit award, in which each stock unit represents a right to receive one share of issuer common stock, which award will vest, subject to the reporting person's continued service with the issuer, as follows: (i) 5/12 of the total number of units will vest on September 10, 2026 and (ii) the remaining units will vest in equal installments as of the 10th day of the third month of each of the seven calendar quarters thereafter.

2. Each Performance Restricted Stock Unit ("PRSU") represents a right to receive one share of issuer common stock, with the total number of units reflecting the number that are eligible to be earned at target-level performance achievement. Upon achievement of the maximum level of the applicable performance criteria, the reporting person may become eligible to earn 200% of the target number of units.

3. The PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as follows: (i) 34% of the earned award will vest on September 10, 2026 (ii) 33% of the earned award will vest on September 10, 2027 and (iii) 33% of the earned award will vest on September 10, 2028.

Remarks:

	/s/ Alissa Neufeld	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Lifevantage (LFVN) reporting person receive on 08/26/2025?

The reporting person received 9,036 stock units and 13,554 Performance Restricted Stock Units (PRSUs) on 08/26/2025 as reported on the Form 4.

How many shares does Alissa Neufeld beneficially own after the reported transaction?

After the transaction, the Form 4 reports 100,605 shares of common stock beneficially owned and 13,554 PRSU equivalents.

When do the stock units and PRSUs vest for the LFVN grant?

Stock units: 5/12 vest on Sept 10, 2026, remainder vests in equal installments on the 10th day of the third month of each of seven subsequent calendar quarters. PRSUs: contingent on performance with 34% vesting Sept 10, 2026, 33% Sept 10, 2027, and 33% Sept 10, 2028 of any earned award.

What is the payout if performance targets are exceeded for the PRSUs?

The PRSUs may pay up to 200% of the target number of units upon achievement of maximum performance levels, per the Form 4 explanation.

Was any cash paid by the reporting person to acquire these awards?

No cash payment was reported; the Form 4 lists the price as $0 for both the stock units and PRSUs.